Subscribe to our Preterm labor newsletter

 
Subscribe to our Preterm labor newsletter

The challenge of Threatened Preterm Labor

30 %

Positive Predictive Value of current technologies.

OB/GYN doctors do not trust them because of its huge ratio of False Positive TPL Cases
~38 million

Pregnant women

are unnecessarily hospitalized every year due to a false positive result of TPTL test.
US$ 21 thousand

Associated cost

per false Threatened Preterm Labor event
US$1200 million

Economic burden

associated to False Threatened Preterm Labor events for US & EU only.


OUR DEVICE

The FineBirth

helps the OB/GYN Doctor differentiate between false and true preterm labor threats. Innitius’ Fine Birth is a portable diagnostic device that provides the OB/GYN Doctor with a real time risk assessment of spontaneous preterm delivery within the following ≤ 7 days after the event, dramatically reducing the negative clinical impact and the cost of over-treating false Preterm Labor (PTL) threats.

OUR DEVICE

The FineBirth

helps the OB/GYN Doctor differentiate between false and true preterm labor threats. Innitius’ Fine Birth is a portable diagnostic device that provides the OB/GYN Doctor with a real time risk assessment of spontaneous preterm delivery within the following ≤ 7 days after the event, dramatically reducing the negative clinical impact and the cost of over-treating false Preterm Labor (PTL) threats.

Point-of-Care diagnostics in real time
No use constraints

Higher accuracy than other methods
Cost-effective

Point-of-Care diagnostics in real time
No use constraints

Higher accuracy than other methods
Cost-effective

parallax background

OUR TECHNOLOGY

Torsional Waves

Innitius’ medical devices develop a novel technology called Torsional Waves, a type of shear elastic waves that propagate through soft tissue, radially and in-depth in a curled geometry.

Torsional Waves are used for the diagnosis of pathologies that manifest themselves through changes in tissue consistency.

Our first product, the FineBirth’s patented intravaginal probe measures the consistency (shear modulus) of the cervical tissue, a highly specific, direct marker of pending birth.

The shear modulus, in combination with other clinical parameters of the pregnant woman, are used by an Artificial Intelligence algorithm to provide a real time assessment of whether the women is experiencing a true or false preterm labor threat and informs health professionals in providing appropriate care.


Download our white paper
What is torsional waves elastography (TWE)?

OUR TECHNOLOGY

Torsional Waves

Innitius’ medical devices develop a novel technology called Torsional Waves, a type of shear elastic waves that propagate through soft tissue, radially and in-depth in a curled geometry.

Torsional Waves are used for the diagnosis of pathologies that manifest themselves through changes in tissue consistency.

Our first product, the FineBirth’s patented intravaginal probe measures the consistency (shear modulus) of the cervical tissue, a highly specific, direct marker of pending birth.

The shear modulus, in combination with other clinical parameters of the pregnant woman, are used by an Artificial Intelligence algorithm to provide a real time assessment of whether the women is experiencing a true or false preterm labor threat and informs health professionals in providing appropriate care.


Download our white paper
What is torsional waves elastography (TWE)?
parallax background
 
 

Innitius provides Actionable Diagnostic applications for Women’s Health.

The company was founded in late 2017 as a spinoff of the University of Granada and the Andalusian Health Service (SAS).

Innitius is currently in the clinical evaluation stage, with plans to enter the market
by the end of 2023 with its first
product: the FineBirth.

Visit our linkedin page for more info.
CONTACT

Any Questions?

If you have any questions regarding the company, the technology or you are seriously considering investing in the project, please feel free to contact us

    Innitius provides Actionable Diagnostic applications for Women’s Health.

    The company was founded in late 2017 as a spinoff of the University of Granada and the Andalusian Health Service (SAS).

    Innitius is currently in the clinical evaluation stage, with plans to enter the market
    by the end of 2023 with its first
    product: the FineBirth.

    Visit our linkedin page for more info.
    CONTACT

    Any Questions?

    If you have any questions regarding the company, the technology or you are seriously considering investing in the project, please feel free to contact us